• Add this page to "Favorite pages"
  • Print the text(Open link in a new browser window)
Here begins the text.

PMDA-ATC GMP Inspection Seminar 2017

with the support of PIC/S


    The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce the holding of the "PMDA-ATC GMP Inspection Seminar 2017" for GMP inspectors from overseas regulatory authorities. This Seminar is organized by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC) with the support of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S).
    This Seminar will be held in Yamaguchi prefecture, Japan, from July 31 to August 4, 2017.
    The primal object of this Seminar will be Risk-based Inspection and Data Integrity.  We will offer practical training in the form of a mock inspection. Target participants will be GMP inspectors at beginner or intermediate level. This Seminar will enable inspectors to conduct risk-based GMP inspection.

    Participation from many regulatory authorities is welcomed.


Vaccine focused on aseptic technique.

Key Seminar Objective

The Seminar is designed to address three key areas:

  1. Through group discussions on inspection planning of a mock inspection, participants will focus on abstraction of risks of each processes and consider risk mitigation

- Understand key points that will have an impact to product quality
- Grope risk mitigation method

  1. Confirm site response and understand risk controlled manufacturing process

- Compare key points of risks that are abstracted at inspection planning and practical condition
- Understand the rationale behind discrepancy

  1. The method which site applied to accomplish Data Integrity

- Understand the gap of soft and hard
- Understand the site’s approach to increase level of security using systems

Who should apply

  • Inspectors from regulatory authorities at beginner or intermediate level; maximum 15 participants.
  • If PMDA received more than 15 registration forms, eligible person will be selected.

The training will be provided in English (with consecutive translation in some sessions).
All participants are expected to actively participate in all of the sessions.

Date / Time

July 31 to August 4, 2017. See attached draft program (updated: as of June 20, 2017) for schedule.

Program (subject to change)

See attached draft program (updated: as of June 20, 2017).

Registration (Registration is closed.)

  • Registration request should be made by filling in all the necessary items on the application form and sending it by e-mail to the e-mail address shown in “Contact Us” below.
  • Registration will close on May 10, 2017.
  • Early registration is recommended. The registration may close before the deadline depending on the number of application. Also, please be sure to allow enough time to obtain the visa for entry to Japan.
  • If the number of applications exceeds the capacity, the number of participants from each country may be limited.
  • Confirmation of the registration and additional meeting information will be sent to the approved participants after the close of registration.


There is no registration fee for this Seminar.
Information on travel and hotel reservation assistance will be announced to the approved participants.


Hikari city, Yamaguchi prefecture, Japan
Visit the web site below for detailed travel guide of Yamaguchi prefecture.

Contact Us

For more information, please contact:

Secretariat, PMDA Asia Training Center
E-mail: PMDA-ATC●pmda.go.jp

Office of International Cooperation
Pharmaceuticals and Medical Devices Agency
Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

(Note: For the purpose of security, @ in the e-mail addresses are replaced with ●. Please replace ● with @ when you send an e-mail.)

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.